Add BrightSurf on Google Email

The Nucleotide Analogue Bemnifosbuvir Inhibits Hepatitis E Virus Replication in Preclinical Models

Home | Story
2 institutional releases

Published in Gut · View the paper (DOI)

Researchers have discovered a promising active substance, bemnifosbuvir, that inhibits hepatitis E virus replication and liver inflammation. The study found that bemnifosbuvir effectively blocked the replication of the virus in cell cultures and animal experiments.

Coverage from 2 institutions

  • Promising active substance against hepatitis E identified
    • Article 1 Ruhr-University Bochum · Mar 20, 2026 · first to report
    • Article 2 German Center for Infection Research · Mar 20, 2026